Cerebrovascular Accident Stroke
Conditions
Interventions
None listed
Sponsors
Revalidatiecentrum De Hoogstraat
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria patient: 1). Symptomatic stroke (ischemic or intracerebral haemorrhagic lesion), if possible verified by CT and/or MRI scan. 2). Age at least 18 years. 3). Written informed consent. ;inclusion criteria partner: 1). The partner must be married or live together with the patient. 2). The partner (patient) must participate in the study.
Exclusion criteria
Exclusion criteria: Exclusion criteria patient: 1). Insufficient command of the Dutch language in order to participate and understand questionnaires, based on clinical judgement. 2). Pre-existent dependence in activities of daily living as defined by a pre-morbid Barthel Index below 18. 3.) pre-existent cognitive decline as defined by a score of 1 or higher on the HAC (Heteroanamnesis List Cognition). 4). Co-morbidity: A serious condition whereby an interference with the outcomes of the study is expected, (such as a psychiatric disorder whereby a person is under supervision of a psychiatrist or a serious cardiac disease), or a disease with a progressive course (such as cancer, arthritis, multiple sclerosis, dementia) or a life-threatening condition resulting in a life expectancy less than 6 months (such as a high risk of death from stroke or terminal kidney insufficiency).;Exclusion criteria partner: 1). Insufficient command of the Dutch language in order to participate and understand questionnaires, based on clinical judgement. 2). Pre-existent dependence in activities of daily living as defined by a pre-morbid Barthel Index below 18. 3). Co-morbidity: A serious condition whereby an interference with the outcomes of the study is expected, (such as a psychiatric disorder whereby a person is under supervision of a psychiatrist or a serious cardiac disease), or a disease with a progressive course (such as cancer, arthritis, multiple sclerosis, dementia) or a life-threatening condition resulting in a life expectancy less than 6 months (such as a high risk of death from stroke or terminal kidney insufficiency).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study is participation of stroke patients. Participation will be measured with the Utrecht Scale for Evaluation of Clinical Rehabilitation - Participation (USER-P). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes of this study are: quality of life, life satisfaction and emotional functioning of stroke patients and their partners. These outcomes will be measured with the following measurements: -Quality of Life will be assessed by two measures. The first measure assesses stroke health-related quality of life (short Stroke Specific QoL Questionnaire,SS-QoL-12). The second measure assesses generic health-related quality of life in terms of utilities (Six Dimension Euro-QoL instrument, EQ-6D). -Life Satisfaction will be assessed with three questions which ask for satisfaction with life before the stroke, now and a comparison between before and now. -Emotional functioning will be assessed in terms of depression and anxiety (Hospital Anxiety and Depression Scale, HADS) | — |
Countries
Netherlands
Outcome results
None listed